血液透析患者動靜脈瘻管阻塞原因及預防與居家照護

Associated Factors and Prevention of Fistula Obstruction and Home Care for Arteriovenous Fistula for Patients with Hemodialysis

10.3966/172674042017091603001

呂淑卿(Shu-Ching Lu)；李碧霞(Pi-Hsia Lee)；謝湘俐(Hsiang-Li Hsieh)；莊宇慧(Yeu-Hui Chuang)

血液透析 ； 動靜脈瘻管 ； 居家照護 ； hemodialysis ； arteriovenous fistula (AV fistula) ； home care

臺灣腎臟護理學會雜誌

16卷3期（2017 / 09 / 01）

1 - 12

繁體中文

動靜脈瘻管是血液透析患者接受透析治療的主要血管通路，瘻管阻塞將影響透析治療的進行，引發各種合併症，甚至造成病患的死亡。臨床上導致瘻管功能不良的原因除了血栓、血管狹窄及護理人員欠缺正確的照護知能外，還包括病患自我照顧知識與技巧不足。因此，增加血液透析病患及家屬的瘻管照護知識，是降低血管通路阻塞相當重要的一環。因此本文藉由血管通路的簡介、動靜脈瘻管功能評估、阻塞原因與預防及居家照護方式的說明，期望護理人員能具備正確的照護知能，並能教導病患及家屬動靜脈瘻管居家照護方式，降低瘻管阻塞的發生，延長使用壽命，進而減少醫療支出，提升病患之生活品質。

Arteriovenous fistula (AV fistula) is an important vascular access route for patients who need hemodialysis. When AV fistula is blocked, it will affect treatment, cause various complications and even lead to death. Fistula blockages or malfunction is caused not only by thrombosis, vascular stenosis or lack of knowledge about AV fistula care among nurses, but also by patients' lack of knowledge and skills for AV fistula care at home. Therefore, it is important to improve self-care knowledge of AV fistula for patients and their families in order to reduce the incidence of fistula clogging. This paper is going to introduce vascular access, assessment the function of AV fistula, the associated factors of fistula obstruction, and self-care knowledge and skills. After reading this paper, nurses will acquire correct care knowledge and know-how to teach patients and families about AV fistula care at home. Consequently, it might decrease occurrence of fistula blockage, prolong the life of fistula, reduce medical cost, and improve patient's quality of life.

1. 洪燕妮,吳肖琪,吳義勇,柯博仁(2009)。採用動靜脈瘻管或人工血管之血液透析病人住院醫療利用分析。台灣公共衛生雜誌，28(2)，144-154。
   連結：
2. 葉美鈴,黃惠喧,林妘(2016)。降低血液透析病人動靜脈瘻管阻塞之專案。志爲雜誌，15(5)，80-90。
   連結：
3. Chen, S. C.,Chang, J. M.,Hwang, S. J.,Tsai, J. C.,Wang, C. S.,Mai, H. C,Lin, F. H.,Su, H. M.,Chen, H. C.(2009).Significant correlation between ankle-brachial index and vascular access failure in hemodialysis patients.Clinical Journal of the American Society of Nephrology,4(1),128-134.
4. Deaver, K.(2010).Preventing infections in hemodialysis fistula and graft vascular accesses.Nephrology Nursing Journal,37(5),503.
5. Fisher, L.,Cairns, H. S.,Amir-Ansari, B. E. H. Z. A. D.,Scoble, J. E.,Chalder, T.,Treasure, J.(2006).Psychological intervention in fluid management.Palliative & supportive care,4(4),419-424.
6. Gagliardi, G. M.,Mancuso, D.,Falbo, E.,Mollica, F.,Mollica, A.,Barcellona, E.,Bonofiglio, R.(2012).Anthropometric parameters of nutritional assessment as predictive factors of arteriovenous fistula malfunction in patients undergoing hemodialysis.The Journal of Vascular Access,13(4),475-481.
7. Gilpin, V.,Nichols, W. K.(2010).Vascular access for hemodialysis: Thrills and thrombosis.Journal of Vascular Nursing,28(2),78-83.
8. Hsu, Y. H.,Chen, Y. C.,Chen, T. H.,Sue, Y. M.,Cheng, T. H.,Chen, J. R.,Chen, C. H.(2012).Far-infrared therapy induces the nuclear translocation of PLZF which inhibits VEGF-induced proliferation in human umbilical vein endothelial cells.PLOS One,7(1),e30674.
9. Lin, C. C.,Chung, M. Y.,Yang, W. C.,Lin, S. J.,Lee, P. C.(2013).Length polymorphisms of heme oxygenase-1 determine the effect of far-infrared therapy on the function of arteriovenous fistula in hemodialysis patients: a novel physicogenomic study.Nephrology Dialysis Transplantation,28(5),1284-1293.
10. Lin, C. C.,Yang, W. C.(2009).Prognostic factors influencing the patency of hemodialysis vascular access: Literature review and novel therapeutic modality by far infrared therapy.Journal of the Chinese Medical Association,72(3),109-116.
11. Lin, C. C.,Yang, W. C.,Chen, M. C.,Liu, W. S.,Yang, C. Y.,Lee, P. C.(2013).Effect of far infrared therapy on arteriovenous fistula maturation: An open-label randomized controlled trial.American Journal of Kidney Diseases,62(2),304-311.
12. Lindberg, M.,Fernandes, M. A. M.(2010).Self-efficacy in relation to limited fluid intake amongst Portuguese hemodialysis patients.Journal of Renal Care,36(3),33-138.
13. Lok, C. E.,Foley, R.(2013).Vascular access morbidity and mortality: trends of the last decade.Clinical Journal of the American Society of Nephrology,8(7),1213-1219.
14. McCann, M.,Einarsdóttir, H.,Van Waeleghem, J. P.,Murphy, F.,Sedgwick, J.(2008).Vascular access management 1: An overview.Journal of Renal Care,34(2),77-84.
15. Miguel, S. S.(2010).Hemodialysis dry weight assessment: a literature review.Renal Society of Australasia Journal,6(1),19-24.
16. National Kidney Foundation(2006).,未出版
17. Pantelias, K.,Grapsa, E.(2012).Vascular access today.World Journal of Nephrology,1(3),69-78.
18. Rose, D. A.,Sonaike, E.,Hughes, K.(2013).Hemodialysis access.Surgical Clinics of North America,93(4),997-1012.
19. Salimi, F.,Majd-Nassiri, G.,Moradi, M.,Keshavarzian, A.,Farajzadegan, Z.,Saleki, M.,Ghane, M.(2013).Assessment of effects of upper extremity exercise with arm tourniquet on maturity of arteriovenous fistula in hemodialysis patients.The Journal of Vascular Access,14(1),60.
20. Santoro, D.,Benedetto, F.,Mondello, P.,Pipit, N.,Barill, D.,Spinelli, F.,Buemi, M.(2014).Vascular access for hemodialysis: current perspectives.International Journal of Nephrology and Renovascular Disease,7(1),281-294.
21. Shetty, A.,Whittier, W. L.(2011).Does regular surveillance improve the long-term survival of arteriovenous fistula.International journal of nephrology,2012
22. Smith, G. E.,Gohil, R.,Chetter, I. C.(2012).Factors affecting the patency of arteriovenous fistulas for dialysis access.Journal of Vascular Surgery,55(3),849-855.
23. Ulusoy, S.,Güngör,, E.,Ozkan, G.,Karahan, S. C.,Sit, D.,Bıçak(2013).Do hemodialysis adequacy data reflect reality?.Artificial organs,37(2),189-195.
24. United States Renal Data system(2015).,未出版
25. 白玉玲,丘周萍(2011)。血液透析病人體液容積過量的照護。源遠護理，5(1)，5-10。
26. 江文秀,徐苑綺,李若渝,王春葉,李建德(2009)。經皮血管成術(PTA)於動靜脈痩管阻塞之應用與照護。腎臟與透析，27(2)，177-181。
27. 江銘彥,呂宜樺,王嬋婷,黃志強(2013)。血液透析病人之慢性低血壓之臨床特質及其長期預後。腎臟與透析，25(4)，259-263。
28. 何昭中(2013)。血液透析患者使用永久性血管通路之評估與護理。臺灣腎臟護理學會雜誌，12(1)，7-17。
29. 吳美珠,陳藝娟,黃凰如,黃美莉,林志慶(2012)。血管通路的理學檢查。腎臟與透析，24(2)，133-135。
30. 吳淑榕,馮兆康,高玉貞,黃文鈺,高銘聰,高清添(2010)。病患周邊動脈疾病盛行率及相關因素。澄清醫院管理雜誌，6(2)，13-20。
31. 岳芳如柯乃赞,顏妙芬(2014)。以系統性文獻回顧探討遠紅外線維護血液透析患者自體動靜脈瘻管之成效。護理雜誌，61(6)，78-86。
32. 施鳴凰,簡慧足,游金靖,吳玉鳳(2015)。血管運動對血液透析病患動靜脈瘻管直徑成效之統合分析。護理暨健康照護研究，11(4)，308-316。
33. 郭曉萍(2016)。義守大學醫務管理學系研究所。
34. 曾明晰(2012)。瘻管維護秘笈-運用身評技巧於慢性透析病人動靜脈瘻管的功能評估。臺灣腎臟護理學會雜誌，11(1)，19-20。
35. 黃志強(2012).血液透析學.台北市:合記圖書.
36. 詹淑貞,楊麗瑟(2002)。正反方向穿刺動靜脈瘻管對血液透析中再循環率之影響。腎臟與透析，14(1)，38-43。
37. 臺灣腎臟醫學會(2012,5月16日) 2009年臺灣地區透析人口盛行率, 取自http://www.tsn.org.tw/ui/h/h002. aspx.pdf
38. 賴宇軒,方德昭(2012)。動靜脈瘻管狹窄與栓塞之預防與治療。腎臟與透析，24(4)，249-253。
39. 賴麗英,蕭淑惠,李仁慈,楊惠美,陳建文(2010)。血液透析病患動靜脈瘻管使用年限與 PTA 治療之分析。腎臟與透析，22(3)，210-215。
40. 謝湘俐,楊惠娟,盧國城(2009)。血液透析病患動靜脈瘻管的鈕扣孔穿刺技術。腎臟與透析，21(1)，68-73。
41. 嚴宏文,林志慶,楊五常,吳采虹(2015)。血液透析病患血管通路的長期維護與監測。腎臟與透析，27(1)，14-18。

1. 蕭佳琪(Chia-Chi Hsiao);蕭亞欣(Ya-Hsin Hsiao)(2021)。照護一位長期血液透析罹患卵巢癌後接受化學治療護理經驗。彰化護理。28(3)。104-114。 
2. 宋柔郁(Rou-Yu Sung);涂嘉玲(Chia-Ling Tu);楊巧慧(Chaio-Hui Yang);廖淑櫻(Su-Ying Liao);戴辛翎(Hsin-Ling Tai);李榮芬(Jung-Fen Lee)(2024)。提升血液透析病人動靜脈瘻管血流量之改善方案。榮總護理。41(2)。177-184。